MAM
TERN

Meeder Asset Management’s Terns Pharmaceuticals TERN Stock Holding History

Meeder Asset Management’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.27K Buy
+62
New +$2.55K ﹤0.01% 836
2024
Q3 		– Sell
-772
Closed -$5.26K – 953
2024
Q2 		$5.26K Buy
+772
New +$4.68K ﹤0.01% 769

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Meeder Asset Management's TERN Position: Q1 2026 in Review

Meeder Asset Management opened a new position in Terns Pharmaceuticals (TERN) in Q1 2026: 62 shares worth $3.27K. The stake represents ﹤0.01% of the portfolio and ranks #836 among its holdings. This is a return to the name: Meeder Asset Management previously reported a position in TERN as recently as Q2 2024.

Meeder Asset Management first reported a position in TERN in Q2 2024 and has held it in 2 quarters since. The position peaked at $5.26K in Q2 2024. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Meeder Asset Management held 62 shares of Terns Pharmaceuticals worth $3.27K as of Q1 2026.
  • Terns Pharmaceuticals was a new Meeder Asset Management position in Q1 2026.
  • Terns Pharmaceuticals made up ﹤0.01% of Meeder Asset Management's portfolio in Q1 2026, its #836 holding.
  • Meeder Asset Management first reported a position in Terns Pharmaceuticals in Q2 2024 and has held it in 2 quarters since.
  • Meeder Asset Management's Terns Pharmaceuticals position peaked at $5.26K in Q2 2024.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.